Stock Research for NCTY

NCTY

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

NCTY Stock Chart & Research Data

The NCTY chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NCTY chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


NCTY Due diligence Resources & Stock Charts

The NCTY stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NCTY Detailed Price Forecast - CNN Money CNN View NCTY Detailed Summary - Google Finance
Yahoo View NCTY Detailed Summary - Yahoo! Finance Zacks View NCTY Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View NCTY Trends & Analysis - Trade-Ideas Barrons View NCTY Major Holders - Barrons
NASDAQ View NCTY Call Transcripts - NASDAQ Seeking View NCTY Breaking News & Analysis - Seeking Alpha
Spotlight View NCTY Annual Report - CompanySpotlight.com OTC Report View NCTY OTC Short Report - OTCShortReport.com
TradeKing View NCTY Fundamentals - TradeKing Charts View NCTY SEC Filings - Bar Chart
WSJ View Historical Prices for NCTY - The WSJ Morningstar View Performance/Total Return for NCTY - Morningstar
MarketWatch View the Analyst Estimates for NCTY - MarketWatch CNBC View the Earnings History for NCTY - CNBC
StockMarketWatch View the NCTY Earnings - StockMarketWatch MacroAxis View NCTY Buy or Sell Recommendations - MacroAxis
Bullish View the NCTY Bullish Patterns - American Bulls Short Pains View NCTY Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View NCTY Stock Mentions - StockTwits PennyStocks View NCTY Stock Mentions - PennyStockTweets
Twitter View NCTY Stock Mentions - Twitter Invest Hub View NCTY Investment Forum News - Investor Hub
Yahoo View NCTY Stock Mentions - Yahoo! Message Board Seeking Alpha View NCTY Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for NCTY - SECform4.com Insider Cow View Insider Transactions for NCTY - Insider Cow
CNBC View NCTY Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NCTY - OTC Markets
Yahoo View Insider Transactions for NCTY - Yahoo! Finance NASDAQ View Institutional Holdings for NCTY - NASDAQ


Stock Charts

FinViz View NCTY Stock Insight & Charts - FinViz.com StockCharts View NCTY Investment Charts - StockCharts.com
BarChart View NCTY Stock Overview & Charts - BarChart Trading View View NCTY User Generated Charts - Trading View




Latest Financial News for NCTY


The9 Full Year 2023 Earnings: CN¥40.61 loss per share (vs CN¥406 loss in FY 2022)
Posted on Thursday April 18, 2024

The9 ( NASDAQ:NCTY ) Full Year 2023 Results Key Financial Results Revenue: CN¥179.0m (up 51% from FY 2022). Net loss...


The9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023
Posted on Monday April 15, 2024

The9 Limited (NASDAQ: NCTY) ("The9"), an established Internet company, today announced it filed its annual report on Form 20-F for the year ended December 31, 2023 with the United States Securities and Exchange Commission ("SEC"). The annual report, which contains The9's audited financial statements, can be assessed on the SEC's website at http://www.sec.gov as well as on the Investor Relations section of The9's website at http://www.the9.com.


A New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born
Posted on Monday April 15, 2024

The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) ("WM Therapeutics") has achieved revolutionary breakthroughs in the proprietarily developed research and development of antidepressant drug precision treatment. WM Therapeutics' GenAI multi-dimensional omics drug clinical research technology has made significant progress in new clinical trial, bringing new hope to depression patients.


/C O R R E C T I O N -- The9 Limited/
Posted on Tuesday March 26, 2024

The9 Limited (Nasdaq: NCTY) ("The9"), an established Internet company, today announced that it signed a definitive share purchase agreement (the "Agreement") with WM Therapeutic Co., Ltd. ("WM Therapeutic"), a company operating Generative AI (GenAI) large language model (LLM) multi-dimensional and multi-omics digital precision medicine platform for brain disease, to purchase an additional 21.7% shares of WM Therapeutic by cash and issuance of The9's restricted shares. The9 had invested 8.3% shar


Stock Market & Investing Books

Enter a stock symbol to view the stock details.